CCR5 and HIV-1 infection: Several therapeutic strategies targeting CCR5, either through blockade of the co-receptor or through gene editing techniques to inhibit its expression, have demonstrated the potential of CCR5 ablation to inhibit HIV-1 infection, at least temporarily.